Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Oth

Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Lyophilization or freeze drying is the process in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient, protein, collagen, peptide, oligonucleotide, enzymes, and mAbs (Monoclonal Antibody)
Market Dynamics
Key market players are focusing on increasing product launches and approvals, which is expected drive the growth of the market over forecast period. For instance, in May 2019, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., received the U.S. Food and Drug Administration (FDA) approval for a new dosage form (50 mg) and two new indications for pembrolizumab available as a lyophilized powder (Keytruda): Non–small-cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC). Additionally, in December 2021, Novartis AG, a global healthcare company, announced that the European Commission (EC) approved Xolair (omalizumab) as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe chronic rhinosinusitis with nasal polyps (CRSwNP), where therapy only with INC does not provide adequate disease control.
Key features of the study:
This report provides an in-depth analysis of the global lyophilized product market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lyophilized product market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Merck & Co., Inc., Fresenius Kabi AG, Ciron Drugs & Pharmaceuticals Pvt. Ltd., Glaxosmithkline Plc, Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co. Ltd., BTG PLC, Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, Biogen Inc., Dr. Reddy's Laboratories Ltd., Zydus Cadila, AbbVie Inc., Cipla Inc., Johnson & Johnson Services, Inc., Affy Pharma Private Limited, Jubilant Pharmova Limited, and Biocon
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global lyophilized product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized product market
Detailed Segmentation:
Global Lyophilized Product Market, By Drug Class:
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAIDs
Others
Global Lyophilized Product Market, By Indication:
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
Global Lyophilized Product Market, Packaging Type:
Vial
Syringes
Cartridge
Global Lyophilized Product Market, By Region:
North America
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
U.S.
Canada
Latin America
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug Class
Anti-infective
Antineoplastic
Diuretics
Proton pump inhibitor
Anesthetic
Anticoagulant
NSAID's
Others
By Indication
Infectious Disease
Autoimmune Diseases
Gastrointestinal Diseases
Cancer
Others
By Packaging Type
Vial
Syringes
Cartridge
By Region/Country
South Africa
Central Africa
North Africa
Company Profiles
Sanofi*
Company Highlights
Product Types Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Fresenius Kabi AG
Ciron Drugs & Pharmaceuticals Pvt. Ltd
Glaxosmithkline Plc
Mylan NV.
Pfizer, Inc.
Amneal Pharmaceuticals LLC
Otsuka Holdings Co. Ltd.
BTG PLC
Bristol-Myers Squibb Company
Novartis AG
Takeda Pharmaceutical Company Limited
Biogen Inc.
Dr. Reddy's Laboratories Ltd.
Zydus Cadila
AbbVie Inc.
Cipla Inc.
Johnson & Johnson Services, Inc.
Affy Pharma Private Limited
Jubilant Pharmova Limited
Biocon
“*” marked represents similar segmentation in other categories in the respective section.